Piper Sandler Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)

TipRanksFeb 20 06:31 ET

Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $11

Moomoo NewsFeb 20 06:31 ET

BTIG Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $10

Moomoo NewsFeb 14 07:32 ET

Adaptive Biotechnologies Is Maintained at Sector Outperform by Scotiabank

Dow JonesFeb 13 14:16 ET

Adaptive Biotechnologies Analyst Ratings

BenzingaFeb 13 14:06 ET

Scotiabank Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $12

Moomoo NewsFeb 13 07:31 ET

Stable Performance and Strategic Guidance Support Hold Rating for Adaptive Biotechnologies

TipRanksFeb 13 06:39 ET

TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $10

Moomoo NewsFeb 12 07:32 ET

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Springworks Therapeutics (SWTX)

TipRanksFeb 11 23:25 ET

J.P. Morgan Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $8

Moomoo NewsFeb 10 18:31 ET

Adaptive Biotechnologies Analyst Ratings

BenzingaJan 28 10:26 ET

Goldman Sachs Maintains Neutral on Adaptive Biotechnologies, Raises Price Target to $7.5

BenzingaJan 28 10:24 ET

Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsJan 3 07:31 ET

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Teladoc (TDOC)

TipRanksJan 3 06:42 ET

Adaptive Biotechnologies Analyst Ratings

BenzingaDec 18, 2024 11:00 ET

BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $9

Moomoo NewsDec 18, 2024 07:34 ET

Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Maintains Target Price $7

Moomoo NewsNov 19, 2024 09:31 ET

Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Maintains Target Price $7

Moomoo NewsNov 19, 2024 03:36 ET

Balanced Hold Recommendation for Adaptive Biotechnologies Amid Positive Performance and External Challenges

TipRanksNov 18, 2024 20:56 ET

Scotiabank Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 12, 2024 07:36 ET